American Vanguard Corporation (NYSE: AVD) today announced financial results for the first quarter ended March 31, 2021.
Fiscal 2021 First Quarter Financial Highlights – versus Fiscal 2020 First Quarter:
- Net sales were $116 million in 2021, compared to $96 million in 2020.
- Net income was $3.07 million in 2021, compared to $0.52 million in 2020.
- Earnings per diluted share of $0.10 in 2021, compared to $0.02 in 2020.
- EBITDA1of $12.1 million in 2021, compared to $7.6 million in 2020.
Eric Wintemute, Chairman and CEO of American Vanguard stated: “We are pleased to report a much-improved start to 2021 both at the top and bottom lines, as compared to the prior year. Domestically, after several years of relatively stagnant crop prices, we are beginning to see higher commodity prices, which, in turn, has helped spur demand for both our soybean products and our corn herbicide portfolio. In non-crop uses, we experienced steady demand for mosquito control products, a recovery in the horticulture segment and higher royalties from our essential oil products for consumer use. Internationally, we enjoyed improved performance in Mexico and Brazil, while continuing to expand globally with the additions of Agrinos biological products and the integration of AgNova in Australia. Gross profit margins were just below those of the comparable quarter in 2020, while net income for the quarter was 6 times that of the prior year period.”
He continued: “During the quarter, we kept a focus on balance sheet integrity and controlled inventory levels. We also exercised discipline with respect to operating expense (which declined as a percent of net sales) and debt management within the usual seasonal cycle for our business. Further, we produced profitable results while self-funding strategic growth initiatives, including our SIMPAS prescription application system with the Ultimus tracing/verification platform, which we are positioning as a comprehensive solution for the carbon credit market.”
Mr. Wintemute concluded: “Over the course of 2021, we expect a low double-digit increase in net sales with stronger growth in net income. We look forward to giving you additional detail on market conditions, profitability, working capital considerations and our innovation initiatives during our upcoming earnings call.”
Conference Call
Eric Wintemute, Chairman & CEO, Bob Trogele, COO and David T. Johnson, CFO, will conduct a conference call focusing on operating performance and financial results at 4:30 pm ET / 1:30 pm PT on Thursday, May 6, 2021. Interested parties may participate in the call by dialing 888-506-0062 or 973-528-0011 and enter code 481120 - please call in 10 minutes before the conference is scheduled to begin and ask for the American Vanguard conference.
The conference call will also be webcast live via the News and Media section of the Company’s web site at www.american-vanguard.com. To listen to the live webcast, go to the web site at least 15 minutes early to register, download and install any necessary audio software. If you are unable to listen live, the conference call will be archived on the Company’s web site.
About American Vanguard
American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site at www.american-vanguard.com.
The Company, from time to time, may discuss forward-looking information. Except for the historical information contained in this release, all forward-looking statements are estimates by the Company’s management and are subject to various risks and uncertainties that may cause results to differ from management’s current expectations. Such factors include weather conditions, changes in regulatory policy and other risks as detailed from time-to-time in the Company’s SEC reports and filings. All forward-looking statements, if any, in this release represent the Company’s judgment as of the date of this release.
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands, except share data) (Unaudited) |
||||||||
ASSETS |
||||||||
|
|
March 31, 2021 |
|
|
December 31, 2020 |
|
||
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
13,765 |
|
|
$ |
15,923 |
|
Receivables: |
|
|
|
|
|
|
|
|
Trade, net of allowance for doubtful accounts of $3,979 and $3,297, respectively |
|
|
156,010 |
|
|
|
130,029 |
|
Other |
|
|
10,247 |
|
|
|
8,444 |
|
Total receivables, net |
|
|
166,257 |
|
|
|
138,473 |
|
Inventories |
|
|
172,234 |
|
|
|
163,784 |
|
Prepaid expenses |
|
|
11,221 |
|
|
|
10,499 |
|
Income taxes receivable |
|
|
2,409 |
|
|
|
3,046 |
|
Total current assets |
|
|
365,886 |
|
|
|
331,725 |
|
Property, plant and equipment, net |
|
|
65,945 |
|
|
|
65,382 |
|
Operating lease right-of-use assets |
|
|
11,207 |
|
|
|
12,198 |
|
Intangible assets, net of applicable amortization |
|
|
193,776 |
|
|
|
197,514 |
|
Goodwill |
|
|
50,505 |
|
|
|
52,108 |
|
Other assets |
|
|
18,492 |
|
|
|
18,602 |
|
Deferred income tax assets, net |
|
|
4,213 |
|
|
|
2,764 |
|
Total assets |
|
$ |
710,024 |
|
|
$ |
680,293 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|||||||
Current liabilities: |
|
|
|
|
|
|
|
|
Current installments of other liabilities |
|
$ |
909 |
|
|
$ |
2,647 |
|
Accounts payable |
|
|
60,946 |
|
|
|
59,253 |
|
Deferred revenue |
|
|
32,316 |
|
|
|
43,611 |
|
Accrued program costs |
|
|
53,196 |
|
|
|
45,441 |
|
Accrued expenses and other payables |
|
|
15,865 |
|
|
|
16,184 |
|
Operating lease liabilities, current |
|
|
3,664 |
|
|
|
4,188 |
|
Total current liabilities |
|
|
166,896 |
|
|
|
171,324 |
|
Long-term debt, net |
|
|
143,423 |
|
|
|
107,442 |
|
Operating lease liabilities, long term |
|
|
7,692 |
|
|
|
8,177 |
|
Other liabilities, net of current installments |
|
|
8,453 |
|
|
|
9,054 |
|
Deferred income tax liabilities, net |
|
|
23,514 |
|
|
|
23,560 |
|
Total liabilities |
|
|
349,978 |
|
|
|
319,557 |
|
Commitments and contingent liabilities |
|
|
|
|
|
|
|
|
Stockholders' equity: |
|
|
|
|
|
|
|
|
Preferred stock, $.10 par value per share; authorized 400,000 shares; none issued |
|
|
— |
|
|
|
— |
|
Common stock, $.10 par value per share; authorized 40,000,000 shares; issued 33,874,322 shares at March 31, 2021 and 33,922,433 shares at December 31, 2020 |
|
|
3,389 |
|
|
|
3,394 |
|
Additional paid-in capital |
|
|
95,985 |
|
|
|
96,642 |
|
Accumulated other comprehensive loss |
|
|
(11,825 |
) |
|
|
(9,322 |
) |
Retained earnings |
|
|
290,657 |
|
|
|
288,182 |
|
Less treasury stock at cost, 3,061,040 shares |
|
|
(18,160 |
) |
|
|
(18,160 |
) |
Total stockholders’ equity |
|
|
360,046 |
|
|
|
360,736 |
|
Total liabilities and stockholders' equity |
|
$ |
710,024 |
|
|
$ |
680,293 |
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (In thousands, except per share data) (Unaudited) |
||||||||
|
|
For the three months ended March 31 |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
Net sales |
|
$ |
116,155 |
|
|
$ |
95,962 |
|
Cost of sales |
|
|
(71,024 |
) |
|
|
(57,581 |
) |
Gross profit |
|
|
45,131 |
|
|
|
38,381 |
|
Operating expenses |
|
|
(41,444 |
) |
|
|
(36,545 |
) |
Adjustment to bargain purchase gain on business acquisition |
|
|
(33 |
) |
|
|
— |
|
Operating income |
|
|
3,654 |
|
|
|
1,836 |
|
Change in fair value of an equity investment |
|
|
1,066 |
|
|
|
— |
|
Other income |
|
|
672 |
|
|
|
— |
|
Interest expense, net |
|
|
(946 |
) |
|
|
(1,508 |
) |
Income before provision for income taxes (benefit) and loss on equity method investment |
|
|
4,446 |
|
|
|
328 |
|
Income tax (expense) benefit |
|
|
(1,362 |
) |
|
|
205 |
|
Income before loss from equity method investment |
|
|
3,084 |
|
|
|
533 |
|
Loss from equity method investment |
|
|
(13 |
) |
|
|
(13 |
) |
Net income |
|
$ |
3,071 |
|
|
$ |
520 |
|
Earnings per common share—basic |
|
$ |
0.10 |
|
|
$ |
0.02 |
|
Earnings per common share—assuming dilution |
|
$ |
0.10 |
|
|
$ |
0.02 |
|
Weighted average shares outstanding—basic |
|
|
29,737 |
|
|
|
29,288 |
|
Weighted average shares outstanding—assuming dilution |
|
|
30,523 |
|
|
|
29,948 |
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES ANALYSIS OF SALES (In thousands) (Unaudited) |
||||||||||||||||
|
|
For the three Months Ended March 31 |
|
|||||||||||||
|
|
2021 |
|
|
2020 |
|
|
Change |
|
|
% Change |
|
||||
Net sales: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. crop |
|
$ |
54,755 |
|
|
$ |
50,362 |
|
|
$ |
4,393 |
|
|
|
9 |
% |
U.S. non-crop |
|
|
17,453 |
|
|
|
10,993 |
|
|
|
6,460 |
|
|
|
59 |
% |
Total U.S. |
|
|
72,208 |
|
|
|
61,355 |
|
|
|
10,853 |
|
|
|
18 |
% |
International |
|
|
43,947 |
|
|
|
34,607 |
|
|
|
9,340 |
|
|
|
27 |
% |
Total net sales: |
|
$ |
116,155 |
|
|
$ |
95,962 |
|
|
$ |
20,193 |
|
|
|
21 |
% |
Gross profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. crop |
|
$ |
21,271 |
|
|
$ |
24,245 |
|
|
$ |
(2,974 |
) |
|
|
-12 |
% |
U.S. non-crop |
|
|
9,383 |
|
|
|
4,719 |
|
|
|
4,664 |
|
|
|
99 |
% |
Total U.S. |
|
|
30,654 |
|
|
|
28,964 |
|
|
|
1,690 |
|
|
|
6 |
% |
International |
|
|
14,477 |
|
|
|
9,417 |
|
|
|
5,060 |
|
|
|
54 |
% |
Total gross profit: |
|
$ |
45,131 |
|
|
$ |
38,381 |
|
|
$ |
6,750 |
|
|
|
18 |
% |
Gross margin: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
U.S. crop |
|
|
39 |
% |
|
|
48 |
% |
|
|
|
|
|
|
|
|
U.S. non-crop |
|
|
54 |
% |
|
|
43 |
% |
|
|
|
|
|
|
|
|
Total U.S. |
|
|
42 |
% |
|
|
47 |
% |
|
|
|
|
|
|
|
|
International |
|
|
33 |
% |
|
|
27 |
% |
|
|
|
|
|
|
|
|
Gross margin: |
|
|
39 |
% |
|
|
40 |
% |
|
|
|
|
|
|
|
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) (Unaudited) |
||||||||
|
|
For the three months ended March 31 |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
Net income |
|
$ |
3,071 |
|
|
$ |
520 |
|
Adjustments to reconcile net income to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Depreciation and amortization of fixed and intangible assets |
|
|
5,403 |
|
|
|
4,762 |
|
Amortization of other long-term assets |
|
|
1,200 |
|
|
|
967 |
|
Accretion of discounted liabilities |
|
|
18 |
|
|
|
4 |
|
Amortization of deferred loan fees |
|
|
81 |
|
|
|
59 |
|
Provision for bad debts |
|
|
682 |
|
|
|
359 |
|
Loan principal and interest forgiveness |
|
|
(672 |
) |
|
|
— |
|
Stock-based compensation |
|
|
1,792 |
|
|
|
1,357 |
|
Decrease in deferred income taxes |
|
|
(269 |
) |
|
|
(910 |
) |
Change in fair value of an equity investment |
|
|
(1,066 |
) |
|
|
— |
|
Loss from equity method investment |
|
|
13 |
|
|
|
13 |
|
Adjustment to bargain purchase gain on business acquisition |
|
|
33 |
|
|
|
— |
|
Changes in assets and liabilities associated with operations: |
|
|
|
|
|
|
|
|
Increase in net receivables |
|
|
(30,422 |
) |
|
|
(6,578 |
) |
Increase in inventories |
|
|
(9,615 |
) |
|
|
(16,446 |
) |
Increase in prepaid expenses and other assets |
|
|
(1,052 |
) |
|
|
(776 |
) |
(Increase) decrease in income tax receivable/payable, net |
|
|
638 |
|
|
|
(597 |
) |
Decrease in net operating lease liability |
|
|
(18 |
) |
|
|
— |
|
Increase in accounts payable |
|
|
2,293 |
|
|
|
1,617 |
|
Decrease in deferred revenue |
|
|
(11,293 |
) |
|
|
(2,342 |
) |
Increase in accrued program costs |
|
|
7,770 |
|
|
|
6,016 |
|
Decrease in other payables and accrued expenses |
|
|
(1,187 |
) |
|
|
(2,094 |
) |
Net cash used in operating activities |
|
|
(32,600 |
) |
|
|
(14,069 |
) |
Cash flows from investing activities: |
|
|
|
|
|
|
|
|
Capital expenditures |
|
|
(2,904 |
) |
|
|
(2,980 |
) |
Intangible assets |
|
|
(41 |
) |
|
|
— |
|
Net cash used in investing activities |
|
|
(2,945 |
) |
|
|
(2,980 |
) |
Cash flows from financing activities: |
|
|
|
|
|
|
|
|
Net borrowings under line of credit agreement |
|
|
35,900 |
|
|
|
19,400 |
|
Net payments from the issuance of common stock (sale of stock under ESPP, exercise of stock options, and shares purchased for tax withholdings) |
|
|
(2,454 |
) |
|
|
(2,177 |
) |
Payment of cash dividends |
|
|
(593 |
) |
|
|
(582 |
) |
Net cash provided by financing activities |
|
|
32,853 |
|
|
|
16,641 |
|
Net decrease in cash and cash equivalents |
|
|
(2,692 |
) |
|
|
(408 |
) |
Effect of exchange rate changes on cash and cash equivalents |
|
|
534 |
|
|
|
(629 |
) |
Cash and cash equivalents at beginning of period |
|
|
15,923 |
|
|
|
6,581 |
|
Cash and cash equivalents at end of period |
|
$ |
13,765 |
|
|
$ |
5,544 |
|
AMERICAN VANGUARD CORPORATION AND SUBSIDIARIES UNAUDITED RECONCILIATION OF NET INCOME TO EBITDA For the three months March 31, 2021 and 2020 (Unaudited) |
||||||||
|
|
March 31, 2021 |
|
|
March 31, 2020 |
|
||
Net income, as reported |
|
$ |
3,071 |
|
|
$ |
520 |
|
Provision for income taxes |
|
|
1,362 |
|
|
|
(205 |
) |
Interest expense, net |
|
|
946 |
|
|
|
1,508 |
|
Depreciation and amortization |
|
|
6,684 |
|
|
|
5,788 |
|
EBITDA2 |
|
$ |
12,063 |
|
|
$ |
7,611 |
|
1 Earnings before interest, taxes, depreciation, and amortization. EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measure so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define EBITDA differently.
2 Earnings before interest, taxes, depreciation and amortization. EBITDA is not a financial measure calculated and presented in accordance with U.S. generally accepted accounting principles (GAAP) and should not be considered as an alternative to net income (loss), operating income (loss) or any other financial measures so calculated and presented, nor as an alternative to cash flow from operating activities as a measure of liquidity. The items excluded from EBITDA are detailed in the reconciliation attached to this news release. Other companies (including the Company’s competitors) may define EBITDA differently.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210506006193/en/
Contacts
Company Contact:
American Vanguard Corporation
William A. Kuser, Director of Investor Relations
(949) 260-1200
williamk@amvac-chemical.com
Investor Representative:
The Equity Group Inc.
www.theequitygroup.com
Lena Cati
Lcati@equityny.com
